Israel’s Medigus Launches Device to Treat Acid Reflux Without Surgery

TEL AVIV (Reuters) -

Israeli medical device maker Medigus expects revenue of a few million dollars in 2014 as it begins to sell its flexible endoscope for the treatment of acid reflux.

Gastroesophageal reflux disease (GERD) is caused by abnormal regurgitation of fluids from the stomach into the esophagus. Patients who do not respond to treatment with drugs often undergo laparoscopic surgery.

Medigus’s system enables treatment in an outpatient setting with no incisions. Its endoscope — a surgical tool inserted through the mouth — staples the stomach to the wall of the esophagus to close a gap that allows acid to rise up.

A tiny video camera on the tip enables physicians to see what they are doing. Ultrasound guides alignment once the tip reaches tissue blocking the view.